Clinical Trial Update: Evaluation of Tonabersat for DME [Phase 2]

View source ↗

Summary

An active Phase 2 clinical trial is evaluating tonabersat for diabetic macular edema, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Tonabersat (tonabersat)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Macular Edema | Phase 2 | Status: ACTIVE_NOT_RECRUITING